| Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study JJ Szymanski, RT Sundby, PA Jones, D Srihari, N Earland, PK Harris, ... PLoS Medicine 18 (8), e1003734, 2021 | 42 | 2021 |
| Genomic patterns of malignant peripheral nerve sheath tumor (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA I Cortes-Ciriano, CD Steele, K Piculell, A Al-Ibraheemi, V Eulo, MM Bui, ... Cancer discovery 13 (3), 654-671, 2023 | 21 | 2023 |
| Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients PS Chauhan, A Shiang, I Alahi, RT Sundby, W Feng, B Gungoren, ... NPJ Precision Oncology 7 (1), 6, 2023 | 19 | 2023 |
| MEK inhibition synergizes with TYK2 inhibitors in NF1-associated malignant peripheral nerve sheath tumors DC Borcherding, NV Amin, K He, X Zhang, Y Lyu, C Dehner, H Bhatia, ... Clinical Cancer Research 29 (8), 1592-1604, 2023 | 6 | 2023 |
| Liquid biopsies in pediatric oncology: opportunities and obstacles RT Sundby, A Pan, JF Shern Current opinion in pediatrics 34 (1), 39-47, 2022 | 6 | 2022 |
| A phase II trial of guadecitabine in children and adults with SDH-deficient GIST, pheochromocytoma, paraganglioma, and HLRCC-associated renal cell carcinoma JA Ligon, RT Sundby, MF Wedekind, FI Arnaldez, J Del Rivero, L Wiener, ... Clinical Cancer Research 29 (2), 341-348, 2023 | 5 | 2023 |
| Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1–Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome MR Sargen, J Kim, TP Potjer, ME Velthuizen, AE Martir-Negron, Y Odia, ... JAMA dermatology 159 (10), 1112-1118, 2023 | 4 | 2023 |
| Phase I trial of ganitumab plus dasatinib to cotarget the insulin-like growth factor 1 receptor and src family kinase YES in rhabdomyosarcoma S Akshintala, RT Sundby, D Bernstein, JW Glod, RN Kaplan, ME Yohe, ... Clinical cancer research 29 (17), 3329-3339, 2023 | 4 | 2023 |
| Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials RT Sundby, SD Rhodes, E Komlodi-Pasztor, H Sarnoff, V Grasso, ... Clinical Trials 21 (1), 40-50, 2024 | 1 | 2024 |
| Understanding the Potential of Early-Cancer Detection Using Liquid Biopsy in Patients With Hereditary Cancer Syndromes PD R. Taylor Sundby, MD, Jeffrey J. Szymanski, MD, PhD, Paul A. Jones, Aadel ... ASCO Daily News, 2024 | | 2024 |
| Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics RT Sundby, JJ Szymanski, A Pan, PA Jones, SZ Mahmood, OH Reid, ... medRxiv, 2024.01. 18.24301053, 2024 | | 2024 |
| Cell-Free DNA Fragmentomics for Early Detection of Malignant Transformation in NF1 Patients Harboring Plexiform Neurofibromas J Szymanski, RT Sundby, A Pan, PA Jones, PK Harris, A Hirbe, J Shern, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), S21-S22, 2023 | | 2023 |
| Cell-free DNA fragmentomics distinguish between benign, pre-malignant and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 AC Pan, RT Sundby, JJ Szymanski, PA Jones, PK Harris, AA Chaudhuri, ... Cancer Research 83 (7_Supplement), 997-997, 2023 | | 2023 |
| Urine cell-free DNA multi-omics to detect molecular residual disease and predict survival in bladder cancer patients PS Chauhan, AL Shiang, I Alahi, RT Sundby, W Feng, B Gungoren, ... Cancer Research 83 (7_Supplement), 2219-2219, 2023 | | 2023 |
| 86. Whole genome sequencing of mouse derived cell-free DNA to develop a NF1-MPNST-PDX liquid biopsy model P Jones, W Feng, X Zhang, P Harris, T Sundby, F Qaium, J Shern, ... Cancer Genetics 268, 28, 2022 | | 2022 |
| Multimodal Urine Cell-Free DNA-Based Residual Disease Detection and Prognostication in Muscle-Invasive Bladder Cancer Patients A Shiang, PS Chauhan, K Chen, RT Sundby, I Alahi, RK Babbra, W Feng, ... International Journal of Radiation Oncology, Biology, Physics 114 (3), e247, 2022 | | 2022 |
| Liquid biopsy to detect cancer early and sensitively in patients with neurofibromatosis type 1 A Chaudhuri, P Jones, J Szymanski, A Hirbe, R Sundby, J Shern US Patent App. 17/586,676, 2022 | | 2022 |
| Abstract B006: Development of a NF1-MPNST-PDX liquid biopsy model using whole-genome sequencing and quantitative PCR of mouse-derived cell-free DNA PA Jones, W Feng, X Zhang, PK Harris, T Sundby, JJ Szymanski, ... Clinical Cancer Research 28 (18_Supplement), B006-B006, 2022 | | 2022 |
Jack F ShernNational Cancer InstituteVerified email at nih.gov
